title: The value proposition of molecular medicine.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. scott.waldman@jefferson.edu
authors.forename: Scott A
authors.initials: SA
authors.lastname: Waldman
authors.forename: Andre
authors.initials: A
authors.lastname: Terzic
mesh_terms: D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D020022:Genetic Predisposition to Disease; D017048:Health Care Costs; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000191:economics; D058990:Molecular Targeted Therapy / Q000191:economics; D009369:Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000235:genetics / Q000628:therapy*; D057285:Precision Medicine / Q000191:economics; D011237:Predictive Value of Tests; D016896:Treatment Outcome